🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 141 (from laksa060)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa141.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://www.mofa.go.jp/ca/fna/page24e_000317.html\')), getAhrefsUnparsedNoserviceFromURL(\'https://www.mofa.go.jp/ca/fna/page24e_000317.html\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html","crawl_time":1775512681,"first_indexed_time":1633087871,"http_code":200,"src_unparsed":"jp,go,mofa!www,\/ca\/fna\/page24e_000317.html s443","src_root_hash":"7609941824417276541","history_drop_reason":null,"meta_title":"COVID-19 Vaccination Certificates Valid for Entry into Japan from Abroad | Ministry of Foreign Affairs of Japan","meta_descriptions":[""],"attrs_boilerpipe_text":"In applying measures based on New Border Measures (28) (May 20, 2022), COVID-19 vaccination certificates recognized as valid since July 31, 2022, in principle, fall under any of the categories 1. or 2. below.\nCOVID-19 vaccination certificates issued in Japan which fall under any of the categories (1)-(3) below, and prove that at least three doses of COVID-19 vaccine are inoculated.\n(1) COVID-19 vaccination certificates issued by either the Government of Japan or a local public authority\/municipality in Japan (The COVID-19 Vaccination Certificate for overseas travel)\n(2) Documents to prove vaccination for COVID-19 issued by a local public authority\/municipality in Japan\n(3) Records of Vaccination for COVID-19 issued by medical institutions in Japan\nCOVID-19 vaccination certificates issued abroad which fulfill all the three requirements (1)-(3) below.\n(1) All relevant items described below should be listed on the certificate either in Japanese or English:\nName, date of birth, product name or manufacturer of vaccines, vaccination date, number of COVID-19 vaccine doses (Note 1)\n(Note 1) COVID-19 vaccination certificates written in languages other than Japanese or English are considered as valid if the translation (Japanese\/English) is attached and all the items are clearly identifiable.\n(2) The certificate should prove that at least two doses (As for JCOVDEN \/ Janssen, one dose is treated as two doses) of any of the COVID-19 vaccines described in the table a. below are inoculated, and any of the COVID-19 vaccines described in the table b. below is inoculated for the third vaccination or after. (Note 2)\na. COVID-19 vaccines up to the second dose:\nProduct Name or Manufacturer\nCOMIRNATY, Intramuscular injection \/ Pfizer\nVaxzevria, Intramuscular injection \/ AstraZeneca (Note 3)\nSpikevax, Intramuscular injection \/ Moderna\nJCOVDEN \/ Janssen\nCOVAXIN \/ Bharat Biotech\nNuvaxovid, Intramuscular injection  \/ Novavax (Note 3)\n(Note 2) Mix-and-match vaccines are also considered as valid.\n(Note 3) In applying measures based on New Border Measures (28), COMIRNATY manufactured by Fosun Pharma \/ BioNTech and Covishield \/ COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection \/ Pfizer and Vaxzevria, Intramuscular injection \/ AstraZeneca, Nuvaxovid, Intramuscular injection \/ Novavax respectively.\nb. COVID-19 vaccines for the third dose or after:\nProduct Name or Manufacturer\nCOMIRNATY, Intramuscular injection \/ Pfizer (Note 4)\nSpikevax, Intramuscular injection \/ Moderna\nNuvaxovid, Intramuscular injection \/ Novavax (Note 4)\nVaxzevria, Intramuscular injection \/ AstraZeneca (Note 4)\nJCOVDEN \/ Janssen\nCOVAXIN \/ Bharat Biotech\nNote : To be recognized as valid after 0:00am(JST) July 31, 2022\n(Note 4) In applying measures based on New border measures (28), COMIRNATY manufactured by Fosun Pharma \/ BioNTech and  Covishield \/ COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection \/ Pfizer and Vaxzevria, Intramuscular injection \/ AstraZeneca, Nuvaxovid, Intramuscular injection \/ Novavax respectively.\n(3) The certificate should be issued by an official body, such as a government.","attrs_markdown":"The Ministry of Foreign Affairs website uses JavaScript.  \nPlease turn on \"JavaScript\" and use it.\n\n[![Ministry of Foreign Affairs of Japan](https:\/\/www.mofa.go.jp\/files\/100000047.png)](https:\/\/www.mofa.go.jp\/index.html)\n\n[Skip to main content](https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html#contents \"Move to main text\") [FAQ](https:\/\/www.mofa.go.jp\/feedback\/index.html) [Site Map](https:\/\/www.mofa.go.jp\/infotree\/index.html) [Links](https:\/\/www.mofa.go.jp\/link\/index.html)\n\n[Japanese](https:\/\/www.mofa.go.jp\/mofaj\/index.html)[Other Languages](https:\/\/www.mofa.go.jp\/about\/emb_cons\/over\/multi.html)\n\nFont Size\n\n[S](https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html \"Reduce the font size\")\n\n[M](https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html \"Make the font size standard\")\n\n[L](https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html \"Increase the font size\")\n\n- [About Us](https:\/\/www.mofa.go.jp\/about\/index.html)\n- [News](https:\/\/www.mofa.go.jp\/policy\/culture\/index.html)\n- [Foreign Policy](https:\/\/www.mofa.go.jp\/policy\/index.html)\n- [Countries & Regions](https:\/\/www.mofa.go.jp\/region\/index.html)\n- [Consular Services](https:\/\/www.mofa.go.jp\/p_pd\/ipr\/page7e_900126.html)\n\n[Top](https:\/\/www.mofa.go.jp\/index.html) \\> [Consular Services](https:\/\/www.mofa.go.jp\/p_pd\/ipr\/page7e_900126.html) \\> [Border enforcement measures to prevent the spread of novel coronavirus (COVID-19)](https:\/\/www.mofa.go.jp\/ca\/fna\/page4e_001053.html) \\> COVID-19 Vaccination Certificates Valid for Entry into Japan from Abroad\n\n# Consular Services\n## COVID-19 Vaccination Certificates Valid for Entry into Japan from Abroad\n\nJuly 27, 2022\n\n[Post](https:\/\/twitter.com\/share)\n\n[![e-mail](https:\/\/www.mofa.go.jp\/files\/100000048.gif)](https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html)\n\nIn applying measures based on New Border Measures (28) (May 20, 2022), COVID-19 vaccination certificates recognized as valid since July 31, 2022, in principle, fall under any of the categories 1. or 2. below.\n\n1. COVID-19 vaccination certificates issued in Japan which fall under any of the categories (1)-(3) below, and prove that at least three doses of COVID-19 vaccine are inoculated.\n   - (1) COVID-19 vaccination certificates issued by either the Government of Japan or a local public authority\/municipality in Japan (The COVID-19 Vaccination Certificate for overseas travel)\n   - (2) Documents to prove vaccination for COVID-19 issued by a local public authority\/municipality in Japan\n   - (3) Records of Vaccination for COVID-19 issued by medical institutions in Japan\n2. COVID-19 vaccination certificates issued abroad which fulfill all the three requirements (1)-(3) below.\n   - (1) All relevant items described below should be listed on the certificate either in Japanese or English:  \n      Name, date of birth, product name or manufacturer of vaccines, vaccination date, number of COVID-19 vaccine doses (Note 1)\n     - (Note 1) COVID-19 vaccination certificates written in languages other than Japanese or English are considered as valid if the translation (Japanese\/English) is attached and all the items are clearly identifiable.\n   - (2) The certificate should prove that at least two doses (As for JCOVDEN \/ Janssen, one dose is treated as two doses) of any of the COVID-19 vaccines described in the table a. below are inoculated, and any of the COVID-19 vaccines described in the table b. below is inoculated for the third vaccination or after. (Note 2)\n     - a. COVID-19 vaccines up to the second dose:\n       |   |\n       |---|\n       | Product Name or Manufacturer |\n       | COMIRNATY, Intramuscular injection \/ Pfizer |\n       | Vaxzevria, Intramuscular injection \/ AstraZeneca (Note 3) |\n       | Spikevax, Intramuscular injection \/ Moderna |\n       | JCOVDEN \/ Janssen |\n       | COVAXIN \/ Bharat Biotech |\n       | Nuvaxovid, Intramuscular injection \/ Novavax (Note 3) |\n     - - (Note 2) Mix-and-match vaccines are also considered as valid.\n       - (Note 3) In applying measures based on New Border Measures (28), COMIRNATY manufactured by Fosun Pharma \/ BioNTech and Covishield \/ COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection \/ Pfizer and Vaxzevria, Intramuscular injection \/ AstraZeneca, Nuvaxovid, Intramuscular injection \/ Novavax respectively.\n     - b. COVID-19 vaccines for the third dose or after:\n       |   |\n       |---|\n       | Product Name or Manufacturer |\n       | COMIRNATY, Intramuscular injection \/ Pfizer (Note 4) |\n       | Spikevax, Intramuscular injection \/ Moderna |\n       | Nuvaxovid, Intramuscular injection \/ Novavax (Note 4) |\n       | Vaxzevria, Intramuscular injection \/ AstraZeneca (Note 4) |\n       | JCOVDEN \/ Janssen |\n       | COVAXIN \/ Bharat Biotech  Note : To be recognized as valid after 0:00am(JST) July 31, 2022 |\n     - - (Note 4) In applying measures based on New border measures (28), COMIRNATY manufactured by Fosun Pharma \/ BioNTech and Covishield \/ COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection \/ Pfizer and Vaxzevria, Intramuscular injection \/ AstraZeneca, Nuvaxovid, Intramuscular injection \/ Novavax respectively.\n   - (3) The certificate should be issued by an official body, such as a government.\n***\n## Related Links\n- [Border enforcement measures to prevent the spread of novel coronavirus (COVID-19)](https:\/\/www.mofa.go.jp\/ca\/fna\/page4e_001053.html)\n\n[Page Top](https:\/\/www.mofa.go.jp\/ca\/fna\/page24e_000317.html#header)\n\n[Back to Consular Services](https:\/\/www.mofa.go.jp\/p_pd\/ipr\/page7e_900126.html)\n\n[About Us](https:\/\/www.mofa.go.jp\/about\/index.html)\n\n- [Ministers](https:\/\/www.mofa.go.jp\/about\/page22e_000390.html)\n- [Officials](https:\/\/www.mofa.go.jp\/about\/hq\/list.html)\n- [Organization](https:\/\/www.mofa.go.jp\/about\/hq\/org.html)\n- [Location](https:\/\/www.mofa.go.jp\/about\/hq\/map.html)\n- [Embassies & Consulates](https:\/\/www.mofa.go.jp\/about\/emb_cons\/over\/index.html)\n- [Diplomatic Archives](https:\/\/www.mofa.go.jp\/about\/hq\/record\/index.html)\n- [About this Site](https:\/\/www.mofa.go.jp\/about\/page22e_000497.html)\n\n[News](https:\/\/www.mofa.go.jp\/policy\/culture\/index.html)\n\n- [Press Releases](https:\/\/www.mofa.go.jp\/press\/release\/index.html)\n- [Press Conferences](https:\/\/www.mofa.go.jp\/press\/kaiken\/index.html)\n- [Speeches](https:\/\/www.mofa.go.jp\/p_pd\/ipr\/page22e_000518.html)\n- [Contributions & Interviews](https:\/\/www.mofa.go.jp\/announce\/cai\/index.html)\n- [Other Information](https:\/\/www.mofa.go.jp\/announce\/info\/index.html)\n\n[Foreign Policy](https:\/\/www.mofa.go.jp\/policy\/index.html)\n\n- [Diplomatic Bluebook](https:\/\/www.mofa.go.jp\/policy\/other\/bluebook\/index.html)\n- [Japan's Security \/ Peace & Stability of the International Community](https:\/\/www.mofa.go.jp\/policy\/political_and_security.html)\n- [Global Issues & ODA](https:\/\/www.mofa.go.jp\/policy\/global_and_oda.html)\n- [Economic Diplomacy](https:\/\/www.mofa.go.jp\/policy\/economy\/index.html)\n- [Public Diplomacy](https:\/\/www.mofa.go.jp\/policy\/culture\/public_diplomacy.html)\n- [Others](https:\/\/www.mofa.go.jp\/p_pd\/ipr\/page7e_900124.html)\n\n[Countries & Regions](https:\/\/www.mofa.go.jp\/region\/index.html)\n\n- [Asia](https:\/\/www.mofa.go.jp\/region\/asia-paci\/index.html)\n- [Oceania](https:\/\/www.mofa.go.jp\/region\/asia-paci\/index2.html)\n- [North America](https:\/\/www.mofa.go.jp\/region\/n-america\/index.html)\n- [Latin America and the Caribbean](https:\/\/www.mofa.go.jp\/region\/latin\/index.html)\n- [Europe](https:\/\/www.mofa.go.jp\/region\/europe\/index.html)\n- [Middle East](https:\/\/www.mofa.go.jp\/region\/middle_e\/index.html)\n- [Africa](https:\/\/www.mofa.go.jp\/region\/africa\/index.html)\n\n[Consular Services](https:\/\/www.mofa.go.jp\/p_pd\/ipr\/page7e_900126.html)\n\n- [Visa](https:\/\/www.mofa.go.jp\/j_info\/visit\/visa\/index.html)\n- [Residing in Japan](https:\/\/www.mofa.go.jp\/ca\/fna\/page3e_001006.html)\n- [Certification](https:\/\/www.mofa.go.jp\/ca\/cs\/page22e_000416.html)\n- [Information about Japan (Links)](https:\/\/www.mofa.go.jp\/j_info\/japan\/general\/index.html)\n- [The Hague Convention](https:\/\/www.mofa.go.jp\/fp\/hr_ha\/page22e_000249.html)\n\n- [Legal Matters](https:\/\/www.mofa.go.jp\/about\/legalmatters.html)\n- [Accessibility](https:\/\/www.mofa.go.jp\/about\/accessibility.html)\n- [Privacy Policy](https:\/\/www.mofa.go.jp\/about\/privacy.html)\n- [About this Site](https:\/\/www.mofa.go.jp\/about\/page22e_000497.html)\n\nCopyright © Ministry of Foreign Affairs of Japan\n\nMinistry of Foreign Affairs of Japan 2-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100\\-8919, Japan [MAP](https:\/\/www.mofa.go.jp\/about\/hq\/map.html)Phone: +81\\-(0)3\\-3580\\-3311 Japan Corporate Number(JCN): 9000012040001","attrs_readable_markdown":null,"meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

3 days ago

🤖

ROBOTS ALLOWED

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	0.1 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://www.mofa.go.jp/ca/fna/page24e_000317.html
Last Crawled	2026-04-06 21:58:01 (3 days ago)
First Indexed	2021-10-01 11:31:11 (4 years ago)
HTTP Status Code	200
Meta Title	COVID-19 Vaccination Certificates Valid for Entry into Japan from Abroad \| Ministry of Foreign Affairs of Japan
Meta Description	null
Meta Canonical	null
Boilerpipe Text	In applying measures based on New Border Measures (28) (May 20, 2022), COVID-19 vaccination certificates recognized as valid since July 31, 2022, in principle, fall under any of the categories 1. or 2. below. COVID-19 vaccination certificates issued in Japan which fall under any of the categories (1)-(3) below, and prove that at least three doses of COVID-19 vaccine are inoculated. (1) COVID-19 vaccination certificates issued by either the Government of Japan or a local public authority/municipality in Japan (The COVID-19 Vaccination Certificate for overseas travel) (2) Documents to prove vaccination for COVID-19 issued by a local public authority/municipality in Japan (3) Records of Vaccination for COVID-19 issued by medical institutions in Japan COVID-19 vaccination certificates issued abroad which fulfill all the three requirements (1)-(3) below. (1) All relevant items described below should be listed on the certificate either in Japanese or English: Name, date of birth, product name or manufacturer of vaccines, vaccination date, number of COVID-19 vaccine doses (Note 1) (Note 1) COVID-19 vaccination certificates written in languages other than Japanese or English are considered as valid if the translation (Japanese/English) is attached and all the items are clearly identifiable. (2) The certificate should prove that at least two doses (As for JCOVDEN / Janssen, one dose is treated as two doses) of any of the COVID-19 vaccines described in the table a. below are inoculated, and any of the COVID-19 vaccines described in the table b. below is inoculated for the third vaccination or after. (Note 2) a. COVID-19 vaccines up to the second dose: Product Name or Manufacturer COMIRNATY, Intramuscular injection / Pfizer Vaxzevria, Intramuscular injection / AstraZeneca (Note 3) Spikevax, Intramuscular injection / Moderna JCOVDEN / Janssen COVAXIN / Bharat Biotech Nuvaxovid, Intramuscular injection / Novavax (Note 3) (Note 2) Mix-and-match vaccines are also considered as valid. (Note 3) In applying measures based on New Border Measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively. b. COVID-19 vaccines for the third dose or after: Product Name or Manufacturer COMIRNATY, Intramuscular injection / Pfizer (Note 4) Spikevax, Intramuscular injection / Moderna Nuvaxovid, Intramuscular injection / Novavax (Note 4) Vaxzevria, Intramuscular injection / AstraZeneca (Note 4) JCOVDEN / Janssen COVAXIN / Bharat Biotech Note : To be recognized as valid after 0:00am(JST) July 31, 2022 (Note 4) In applying measures based on New border measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively. (3) The certificate should be issued by an official body, such as a government.
Markdown	The Ministry of Foreign Affairs website uses JavaScript. Please turn on "JavaScript" and use it. [![Ministry of Foreign Affairs of Japan](https://www.mofa.go.jp/files/100000047.png)](https://www.mofa.go.jp/index.html) [Skip to main content](https://www.mofa.go.jp/ca/fna/page24e_000317.html#contents "Move to main text") [FAQ](https://www.mofa.go.jp/feedback/index.html) [Site Map](https://www.mofa.go.jp/infotree/index.html) [Links](https://www.mofa.go.jp/link/index.html) [Japanese](https://www.mofa.go.jp/mofaj/index.html)[Other Languages](https://www.mofa.go.jp/about/emb_cons/over/multi.html) Font Size [S](https://www.mofa.go.jp/ca/fna/page24e_000317.html "Reduce the font size") [M](https://www.mofa.go.jp/ca/fna/page24e_000317.html "Make the font size standard") [L](https://www.mofa.go.jp/ca/fna/page24e_000317.html "Increase the font size") - [About Us](https://www.mofa.go.jp/about/index.html) - [News](https://www.mofa.go.jp/policy/culture/index.html) - [Foreign Policy](https://www.mofa.go.jp/policy/index.html) - [Countries & Regions](https://www.mofa.go.jp/region/index.html) - [Consular Services](https://www.mofa.go.jp/p_pd/ipr/page7e_900126.html) [Top](https://www.mofa.go.jp/index.html) \> [Consular Services](https://www.mofa.go.jp/p_pd/ipr/page7e_900126.html) \> [Border enforcement measures to prevent the spread of novel coronavirus (COVID-19)](https://www.mofa.go.jp/ca/fna/page4e_001053.html) \> COVID-19 Vaccination Certificates Valid for Entry into Japan from Abroad # Consular Services ## COVID-19 Vaccination Certificates Valid for Entry into Japan from Abroad July 27, 2022 [Post](https://twitter.com/share) [![e-mail](https://www.mofa.go.jp/files/100000048.gif)](https://www.mofa.go.jp/ca/fna/page24e_000317.html) In applying measures based on New Border Measures (28) (May 20, 2022), COVID-19 vaccination certificates recognized as valid since July 31, 2022, in principle, fall under any of the categories 1. or 2. below. 1. COVID-19 vaccination certificates issued in Japan which fall under any of the categories (1)-(3) below, and prove that at least three doses of COVID-19 vaccine are inoculated. - (1) COVID-19 vaccination certificates issued by either the Government of Japan or a local public authority/municipality in Japan (The COVID-19 Vaccination Certificate for overseas travel) - (2) Documents to prove vaccination for COVID-19 issued by a local public authority/municipality in Japan - (3) Records of Vaccination for COVID-19 issued by medical institutions in Japan 2. COVID-19 vaccination certificates issued abroad which fulfill all the three requirements (1)-(3) below. - (1) All relevant items described below should be listed on the certificate either in Japanese or English: Name, date of birth, product name or manufacturer of vaccines, vaccination date, number of COVID-19 vaccine doses (Note 1) - (Note 1) COVID-19 vaccination certificates written in languages other than Japanese or English are considered as valid if the translation (Japanese/English) is attached and all the items are clearly identifiable. - (2) The certificate should prove that at least two doses (As for JCOVDEN / Janssen, one dose is treated as two doses) of any of the COVID-19 vaccines described in the table a. below are inoculated, and any of the COVID-19 vaccines described in the table b. below is inoculated for the third vaccination or after. (Note 2) - a. COVID-19 vaccines up to the second dose: \| \| \|---\| \| Product Name or Manufacturer \| \| COMIRNATY, Intramuscular injection / Pfizer \| \| Vaxzevria, Intramuscular injection / AstraZeneca (Note 3) \| \| Spikevax, Intramuscular injection / Moderna \| \| JCOVDEN / Janssen \| \| COVAXIN / Bharat Biotech \| \| Nuvaxovid, Intramuscular injection / Novavax (Note 3) \| - - (Note 2) Mix-and-match vaccines are also considered as valid. - (Note 3) In applying measures based on New Border Measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively. - b. COVID-19 vaccines for the third dose or after: \| \| \|---\| \| Product Name or Manufacturer \| \| COMIRNATY, Intramuscular injection / Pfizer (Note 4) \| \| Spikevax, Intramuscular injection / Moderna \| \| Nuvaxovid, Intramuscular injection / Novavax (Note 4) \| \| Vaxzevria, Intramuscular injection / AstraZeneca (Note 4) \| \| JCOVDEN / Janssen \| \| COVAXIN / Bharat Biotech Note : To be recognized as valid after 0:00am(JST) July 31, 2022 \| - - (Note 4) In applying measures based on New border measures (28), COMIRNATY manufactured by Fosun Pharma / BioNTech and Covishield / COVOVAX manufactured by the Serum Institute of India are treated as identical to COMIRNATY, Intramuscular injection / Pfizer and Vaxzevria, Intramuscular injection / AstraZeneca, Nuvaxovid, Intramuscular injection / Novavax respectively. - (3) The certificate should be issued by an official body, such as a government. *** ## Related Links - [Border enforcement measures to prevent the spread of novel coronavirus (COVID-19)](https://www.mofa.go.jp/ca/fna/page4e_001053.html) [Page Top](https://www.mofa.go.jp/ca/fna/page24e_000317.html#header) [Back to Consular Services](https://www.mofa.go.jp/p_pd/ipr/page7e_900126.html) [About Us](https://www.mofa.go.jp/about/index.html) - [Ministers](https://www.mofa.go.jp/about/page22e_000390.html) - [Officials](https://www.mofa.go.jp/about/hq/list.html) - [Organization](https://www.mofa.go.jp/about/hq/org.html) - [Location](https://www.mofa.go.jp/about/hq/map.html) - [Embassies & Consulates](https://www.mofa.go.jp/about/emb_cons/over/index.html) - [Diplomatic Archives](https://www.mofa.go.jp/about/hq/record/index.html) - [About this Site](https://www.mofa.go.jp/about/page22e_000497.html) [News](https://www.mofa.go.jp/policy/culture/index.html) - [Press Releases](https://www.mofa.go.jp/press/release/index.html) - [Press Conferences](https://www.mofa.go.jp/press/kaiken/index.html) - [Speeches](https://www.mofa.go.jp/p_pd/ipr/page22e_000518.html) - [Contributions & Interviews](https://www.mofa.go.jp/announce/cai/index.html) - [Other Information](https://www.mofa.go.jp/announce/info/index.html) [Foreign Policy](https://www.mofa.go.jp/policy/index.html) - [Diplomatic Bluebook](https://www.mofa.go.jp/policy/other/bluebook/index.html) - [Japan's Security / Peace & Stability of the International Community](https://www.mofa.go.jp/policy/political_and_security.html) - [Global Issues & ODA](https://www.mofa.go.jp/policy/global_and_oda.html) - [Economic Diplomacy](https://www.mofa.go.jp/policy/economy/index.html) - [Public Diplomacy](https://www.mofa.go.jp/policy/culture/public_diplomacy.html) - [Others](https://www.mofa.go.jp/p_pd/ipr/page7e_900124.html) [Countries & Regions](https://www.mofa.go.jp/region/index.html) - [Asia](https://www.mofa.go.jp/region/asia-paci/index.html) - [Oceania](https://www.mofa.go.jp/region/asia-paci/index2.html) - [North America](https://www.mofa.go.jp/region/n-america/index.html) - [Latin America and the Caribbean](https://www.mofa.go.jp/region/latin/index.html) - [Europe](https://www.mofa.go.jp/region/europe/index.html) - [Middle East](https://www.mofa.go.jp/region/middle_e/index.html) - [Africa](https://www.mofa.go.jp/region/africa/index.html) [Consular Services](https://www.mofa.go.jp/p_pd/ipr/page7e_900126.html) - [Visa](https://www.mofa.go.jp/j_info/visit/visa/index.html) - [Residing in Japan](https://www.mofa.go.jp/ca/fna/page3e_001006.html) - [Certification](https://www.mofa.go.jp/ca/cs/page22e_000416.html) - [Information about Japan (Links)](https://www.mofa.go.jp/j_info/japan/general/index.html) - [The Hague Convention](https://www.mofa.go.jp/fp/hr_ha/page22e_000249.html) - [Legal Matters](https://www.mofa.go.jp/about/legalmatters.html) - [Accessibility](https://www.mofa.go.jp/about/accessibility.html) - [Privacy Policy](https://www.mofa.go.jp/about/privacy.html) - [About this Site](https://www.mofa.go.jp/about/page22e_000497.html) Copyright © Ministry of Foreign Affairs of Japan Ministry of Foreign Affairs of Japan 2-2-1 Kasumigaseki, Chiyoda-ku, Tokyo 100\-8919, Japan [MAP](https://www.mofa.go.jp/about/hq/map.html)Phone: +81\-(0)3\-3580\-3311 Japan Corporate Number(JCN): 9000012040001
Readable Markdown	null
Shard	141 (laksa)
Root Hash	7609941824417276541
Unparsed URL	jp,go,mofa!www,/ca/fna/page24e_000317.html s443